In vitro measurement of cytotoxic T cell activity does not predict clinical progression in paediatric HIV disease--two case studies.
Cytotoxic T cells are believed to be an important immune response in HIV infection, both in the initial response to viraemia, and in controlling HIV replication and maintaining clinical stability. We report here the detailed findings in two vertically infected children, from the Edinburgh perinatal cohort. Both were clinically stable for the first 7 years of life. One had vigorous HIV-specific cytotoxic T lymphocyte (CTL) responses, and non-lytic suppression, measured in vitro, while the second had no CTL activity against HIV. Despite her HIV-specific immunity, the first child had a declining CD4 count, and a high and fluctuating viral load, whereas the second child maintained a stable CD4 count, a low viral load and had a virus which could not be cultured in peripheral blood mononuclear cells (PBMC) in vitro. The first child subsequently progressed to AIDS and has now died, while the second remains clinically well. More detailed investigations showed the clinically stable child to be heterozygous for the CCR5 receptor, and to be HLA-B49--both of which markers have been associated with slow HIV disease progression. These findings question the role of CTL in maintaining stable HIV disease, and stress the need for immunological investigations to be considered in the light of the genetic make-up of the patient. They may also reflect a different immunopathogenesis of HIV disease in children compared with adults.
Froebel
K S
KS
Centre for HIV Research, University of Edinburgh, UK.
Mok
J Y
JY
Aldhous
M C
MC
Armitage
M P
MP
Arnott
M
M
Reynolds
L M
LM
Peutherer
J F
JF
Burns
S M
SM
D000328:Adult; D002648:Child; D003602:Cytotoxicity, Immunologic; D005260:Female; D015658:HIV Infections / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy / Q000635:transmission; D015235:HLA-B Antigens / Q000276:immunology; D006801:Humans; D007223:Infant; D018445:Infectious Disease Transmission, Vertical; D011379:Prognosis; D019713:Receptors, CCR5 / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D015235:HLA-B Antigens; D019713:Receptors, CCR5